価格表

在庫・価格 : 2024年05月06日 01時20分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
DNA Damage Assay Kit, In Situ, EpiQuik(192assays)
データシート
P-6001-192 EPGエピジェンテックグループ
Epigentek Group Inc.
1 kit 本製品は取扱中止になりました 追加

在庫・価格 : 2024年05月06日 01時20分 現在

DNA Damage Assay Kit, In Situ, EpiQuik(192assays)

  • 商品コード:P-6001-192
  • メーカー:EPG
  • 包装:1kit
  • 本製品は取扱中止になりました
使用文献
No. 文献情報 備考 参照
1 Yao JY et al. TAp63 plays compensatory roles in p53-deficient cancer cells under genotoxic stress. Biochem. Biophys. Res. Commun. 2010 Dec;403(3-4):310-5
Yao JY et al
2010/01/01
PubMed
2 Hoeferlin LA et al. Activation of p21-Dependent G1/G2 Arrest in the Absence of DNA Damage as an Antiapoptotic Response to Metabolic Stress. Genes Cancer 2011 Sep;2(9):889-99
Hoeferlin LA et al
2011/01/01
PubMed
3 Takeda S et al. (-)-Xanthatin up-regulation of the GADD45γ tumor suppressor gene in MDA-MB-231 breast cancer cells: role of topoisomerase IIα inhibition and reactive oxygen species. Toxicology 2013 Mar;305:1-9
Takeda S et al
2013/01/01
PubMed
4 Błaszczak-Świątkiewicz K et al. Antiproliferative activity of new benzimidazole derivatives. Acta Biochim. Pol. 2013;60(3):427-33
Błaszczak-Świątkiewicz K et al
2013/01/01
PubMed
5 Błaszczak-Świątkiewicz K et al. Biological approach of anticancer activity of new benzimidazole derivatives. Pharmacol Rep 2014 Feb;66(1):100-6
Błaszczak-Świątkiewicz K et al
2014/01/01
PubMed
6 Gravina GL et al. Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models. Prostate 2014 Jun;74(8):852-68
Gravina GL et al
2014/01/01
PubMed
7 Zhao J et al. AKR1C3 overexpression mediates methotrexate resistance in choriocarcinoma cells. Int J Med Sci 2014;11(11):1089-97
Zhao J et al
2014/01/01
PubMed
8 Błaszczak-Świątkiewicz K et al. Biological evaluation of the activity of some benzimidazole-4,7-dione derivatives. Molecules 2014;19(10):15361-73
Błaszczak-Świątkiewicz K et al
2014/01/01
PubMed
9 Sleire L et al. Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc-, leading to glutathione depletion. Oncogene 2015 Dec;34(49):5951-9
Sleire L et al
2015/01/01
PubMed
10 Sarojini S et al. A combination of high dose rate (10X FFF/2400 MU/min/10 MV X-rays) and total low dose (0.5 Gy) induces a higher rate of apoptosis in melanoma cells in vitro and superior preservation of normal melanocytes. Melanoma R
Sarojini S et al
2015/01/01
PubMed
11 Błaszczak-Świątkiewicz K et al. Some characteristics of activity of potential chemotherapeutics--benzimidazole derivatives. Adv Med Sci 2015 Mar;60(1):125-32
Błaszczak-Świątkiewicz K et al
2015/01/01
PubMed
12 Lou JS et al. Yu Ping Feng San reverses cisplatin-induced multi-drug resistance in lung cancer cells via regulating drug transporters and p62/TRAF6 signalling. Sci Rep 2016 Aug;6:31926
Lou JS et al
2016/01/01
PubMed
13 Gravina GL et al. The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models. Tumour Biol. 2017 Jun;39(6):1010428317695528
Gravina GL et al
2017/01/01
PubMed
  • No.: 1
  • 文献情報:
    Yao JY et al. TAp63 plays compensatory roles in p53-deficient cancer cells under genotoxic stress. Biochem. Biophys. Res. Commun. 2010 Dec;403(3-4):310-5
    Yao JY et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Hoeferlin LA et al. Activation of p21-Dependent G1/G2 Arrest in the Absence of DNA Damage as an Antiapoptotic Response to Metabolic Stress. Genes Cancer 2011 Sep;2(9):889-99
    Hoeferlin LA et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Takeda S et al. (-)-Xanthatin up-regulation of the GADD45γ tumor suppressor gene in MDA-MB-231 breast cancer cells: role of topoisomerase IIα inhibition and reactive oxygen species. Toxicology 2013 Mar;305:1-9
    Takeda S et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Błaszczak-Świątkiewicz K et al. Antiproliferative activity of new benzimidazole derivatives. Acta Biochim. Pol. 2013;60(3):427-33
    Błaszczak-Świątkiewicz K et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Błaszczak-Świątkiewicz K et al. Biological approach of anticancer activity of new benzimidazole derivatives. Pharmacol Rep 2014 Feb;66(1):100-6
    Błaszczak-Świątkiewicz K et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Gravina GL et al. Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models. Prostate 2014 Jun;74(8):852-68
    Gravina GL et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Zhao J et al. AKR1C3 overexpression mediates methotrexate resistance in choriocarcinoma cells. Int J Med Sci 2014;11(11):1089-97
    Zhao J et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Błaszczak-Świątkiewicz K et al. Biological evaluation of the activity of some benzimidazole-4,7-dione derivatives. Molecules 2014;19(10):15361-73
    Błaszczak-Świątkiewicz K et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Sleire L et al. Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc-, leading to glutathione depletion. Oncogene 2015 Dec;34(49):5951-9
    Sleire L et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Sarojini S et al. A combination of high dose rate (10X FFF/2400 MU/min/10 MV X-rays) and total low dose (0.5 Gy) induces a higher rate of apoptosis in melanoma cells in vitro and superior preservation of normal melanocytes. Melanoma R
    Sarojini S et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Błaszczak-Świątkiewicz K et al. Some characteristics of activity of potential chemotherapeutics--benzimidazole derivatives. Adv Med Sci 2015 Mar;60(1):125-32
    Błaszczak-Świątkiewicz K et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Lou JS et al. Yu Ping Feng San reverses cisplatin-induced multi-drug resistance in lung cancer cells via regulating drug transporters and p62/TRAF6 signalling. Sci Rep 2016 Aug;6:31926
    Lou JS et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Gravina GL et al. The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models. Tumour Biol. 2017 Jun;39(6):1010428317695528
    Gravina GL et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed